Glen Eagle Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $98.1K | Hold |
332
| – | – | 0.01% | 332 |
|
|
2025
Q4 | $90.5K | Buy |
332
+1
| +0.3% | +$272 | 0.01% | 341 |
|
|
2025
Q3 | $89.5K | Hold |
331
| – | – | 0.01% | 350 |
|
|
2025
Q2 | $91.3K | Hold |
331
| – | – | 0.01% | 325 |
|
|
2025
Q1 | $87.9K | Sell |
331
-32
| -9% | -$7.89K | 0.01% | 323 |
|
|
2024
Q4 | $84.3K | Sell |
363
-50
| -12% | -$11.5K | 0.01% | 333 |
|
|
2024
Q3 | $91.1K | Sell |
413
-149
| -27% | -$30.8K | 0.02% | 327 |
|
|
2024
Q2 | $110K | Buy |
562
+20
| +4% | +$4.13K | 0.02% | 292 |
|
|
2024
Q1 | $117K | Buy |
542
+3
| +0.6% | +$630 | 0.02% | 288 |
|
|
2023
Q4 | $113K | Sell |
539
-23
| -4% | -$4.91K | 0.02% | 283 |
|
|
2023
Q3 | $113K | Buy |
562
+1
| +0.2% | +$199 | 0.03% | 274 |
|
|
2023
Q2 | $104K | Buy |
561
+51
| +10% | +$9.43K | 0.02% | 280 |
|
|
2023
Q1 | $97.6K | Buy |
510
+47
| +10% | +$8.5K | 0.02% | 290 |
|
|
2022
Q4 | $77.9K | Buy |
463
+48
| +12% | +$8.34K | 0.02% | 306 |
|
|
2022
Q3 | $73.4K | Buy |
415
+64
| +18% | +$12.6K | 0.02% | 303 |
|
|
2022
Q2 | $71.9K | Hold |
351
| – | – | 0.02% | 318 |
|
|
2022
Q1 | $83.5K | Buy |
351
+56
| +19% | +$13.2K | 0.02% | 303 |
|
|
2021
Q4 | $67.3K | Buy |
295
+1
| +0.3% | +$220 | 0.02% | 333 |
|
|
2021
Q3 | $56.9K | Hold |
294
| – | – | 0.02% | 356 |
|
|
2021
Q2 | $62.6K | Hold |
294
| – | – | 0.02% | 337 |
|
|
2021
Q1 | $60K | Buy |
294
+1
| +0.3% | +$197 | 0.02% | 316 |
|
|
2020
Q4 | $53.3K | Hold |
293
| – | – | 0.02% | 318 |
|
|
2020
Q3 | $49K | Sell |
293
-19
| -6% | -$3.2K | 0.02% | 308 |
|
|
2020
Q2 | $50.8K | Buy |
312
+179
| +135% | +$32.1K | 0.03% | 285 |
|
|
2020
Q1 | $23K | Buy |
133
+86
| +183% | +$17.1K | 0.02% | 385 |
|
|
2019
Q4 | $9.43K | Sell |
47
-10
| -18% | -$2.05K | 0.01% | 599 |
|
|
2019
Q3 | $12K | Hold |
57
| – | – | 0.01% | 480 |
|
|
2019
Q2 | $11.1K | Buy |
57
+6
| +12% | +$1.11K | 0.01% | 480 |
|
|
2019
Q1 | $8.39K | Sell |
51
-19
| -27% | -$3.36K | 0.01% | 513 |
|
|
2018
Q4 | $13.2K | Hold |
70
| – | – | 0.01% | 420 |
|
|
2018
Q3 | $11.9K | Hold |
70
| – | – | 0.01% | 446 |
|
|
2018
Q2 | $11.5K | Buy |
70
+19
| +37% | +$3.1K | 0.01% | 440 |
|
|
2018
Q1 | $8.25K | Hold |
51
| – | – | 0.01% | 461 |
|
|
2017
Q4 | $7.45K | Hold |
51
| – | – | 0.01% | 469 |
|
|
2017
Q3 | $6.92K | Buy |
51
+5
| +11% | +$632 | 0.01% | 479 |
|
|
2017
Q2 | $9.52K | Sell |
46
-2
| -4% | -$239 | 0.01% | 398 |
|
|
2017
Q1 | $9.03K | Sell |
48
-74
| -61% | -$8.9K | 0.01% | 385 |
|
|
2016
Q4 | $14.1K | Buy |
+122
| New | +$13.6K | 0.01% | 311 |
|
Other funds holding CME
VCM
VPM
Glen Eagle Advisors's CME Position: Q1 2026 in Review
Glen Eagle Advisors held its CME Group (CME) position steady in Q1 2026 at 332 shares worth $98.1K. The position accounts for 0.01% of the portfolio, ranked #332.
Glen Eagle Advisors first reported a position in CME in Q4 2016 and has held it in 38 quarters since. The position peaked at $117K in Q1 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Glen Eagle Advisors held 332 shares of CME Group worth $98.1K as of Q1 2026.
- Glen Eagle Advisors left its CME Group share count unchanged in Q1 2026.
- CME Group made up 0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #332 holding.
- Glen Eagle Advisors first reported a position in CME Group in Q4 2016 and has held it in 38 quarters since.
- Glen Eagle Advisors's CME Group position peaked at $117K in Q1 2024.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.